Location History:
- O'Fallon, MO (US) (2008)
- Mt. Zion, IL (US) (2012 - 2016)
Company Filing History:
Years Active: 2008-2016
Title: The Innovative Mind of James T Smoot: A Pioneer in Anticoagulant Synthesis
Introduction
James T Smoot is a distinguished inventor based in Mt. Zion, Illinois. He holds four patents, demonstrating his significant contributions to the field of biopharmaceuticals. His work primarily focuses on the synthesis of anticoagulants, which have vital applications in medical treatments.
Latest Patents
Among his noteworthy contributions is the patent for a "Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof." This invention encompasses the synthesis of the Factor Xa anticoagulant, fondaparinux, and related compounds. The patent details protected pentasaccharide intermediates and introduces efficient, scalable processes for large-scale industrial production of fondaparinux sodium. These processes involve a series of deprotection and sulfonation reactions that enhance the synthesis efficiency.
Career Highlights
James T Smoot's innovative work is closely associated with Reliable Biopharmaceutical Corporation, where he applies his expertise in developing critical anticoagulants. His contributions in creating scalable production methods illustrate his commitment to advancing pharmaceutical manufacturing.
Collaborations
Throughout his career, Smoot has collaborated with talented colleagues such as Sourena Nadji and Joseph A Vanartsdalen. Together, they have synergized their skills to drive forward important research and development initiatives in the biopharmaceutical sector.
Conclusion
James T Smoot's inventive spirit and dedication to advancing anticoagulant synthesis have made him a notable figure in the field of pharmaceuticals. His patents not only reflect his innovative mindset but also pave the way for improved medical treatments that benefit countless individuals. As he continues his work at Reliable Biopharmaceutical Corporation, the impact of his inventions will likely resonate in the industry for years to come.